A detailed history of Ten Capital Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ten Capital Wealth Advisors, LLC holds 1,045 shares of AMGN stock, worth $296,372. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,045
Previous 571 83.01%
Holding current value
$296,372
Previous $138,000 68.12%
% of portfolio
0.07%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $101,563 - $120,097
474 Added 83.01%
1,045 $232,000
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $14,902 - $18,163
66 Added 13.07%
571 $138,000
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $53,363 - $67,805
233 Added 85.66%
505 $132,000
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $56,788 - $64,046
253 Added 1331.58%
272 $61,000
Q2 2022

Aug 09, 2022

SELL
$230.71 - $256.74 $14,534 - $16,174
-63 Reduced 76.83%
19 $5,000
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $2,631 - $2,910
12 Added 17.14%
82 $20,000
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $14,916 - $17,070
-75 Reduced 51.72%
70 $16,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $1.86 Million - $2.18 Million
-8,776 Reduced 98.37%
145 $31,000
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $9,343 - $10,365
-40 Reduced 0.45%
8,921 $2.17 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $45,713 - $53,271
-206 Reduced 2.25%
8,961 $2.23 Million
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $12,117 - $14,429
56 Added 0.61%
9,167 $2.11 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $2.14 Million - $2.38 Million
9,111 New
9,111 $2.32 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ten Capital Wealth Advisors, LLC Portfolio

Follow Ten Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ten Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ten Capital Wealth Advisors, LLC with notifications on news.